14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session XVII : Cell <strong>signaling</strong> in health <strong>and</strong> disease Poster XVII, 30<br />

15-Deoxy-&12,14-prostagl<strong>and</strong>in J2 covalently modifies <strong>and</strong> functionally inactivates p53<br />

in human breast cancer (MCF-7) cells<br />

Do-Hee Kim, Hye-Kyung Na <strong>and</strong> Young-Joon Surh<br />

National Research Laboratory of Molecular Carcinogenesis <strong>and</strong> Chemoprevention,<br />

College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea<br />

Cyclopentenone prostagl<strong>and</strong>ins (cyPGs) exert diverse cellular functions, such as antiinflammatory<br />

<strong>and</strong> cytoprotective effects. 15-Deoxy- &12,14-prostagl<strong>and</strong>in J2 (15d-PGJ2), a<br />

representative cyPG of the J series, has been reported to exert biphasic effects on proliferation<br />

<strong>and</strong> apoptosis. In the present study, we found that MCF-7 human breast cancer cells treated<br />

with 15d-PGJ2 accumulated the tumor suppressor gene product p53 in both cytosolic <strong>and</strong><br />

nuclear fractions. Under the same experimental conditions, however, the mRNA level of p53<br />

remained unchanged. This prompted us to investigate the molecular mechanisms responsible<br />

for the 15d-PGJ2-mediated accumulation of p53 protein. Murine double-minute 2 (MDM2), a<br />

zinc finger protein, is known to negatively regulate p53. 15d-PGJ2 treatment caused failure of<br />

proper p53-MDM2 interaction in MCF-7 cells which could stabilize p53 protein by blocking<br />

MDM2-mediated degradation. We observed that 15d-PGJ2 covalently modify cysteine<br />

residues of p53 in MCF-7 cells. Covalent modification of p53 by 15d-PGJ2 is considered to<br />

interfere with DNA binding of p53. In support of this assumption, 15d-PGJ2 inhibited the<br />

DNA binding ability of both recombinant p53 <strong>and</strong> MCF-7 nuclear extracts in a concentrationrelated<br />

manner. Likewise, p53 conjugation with 15d-PGJ2 may hamper its interaction with<br />

MDM2, <strong>and</strong> subsequent degradation. The majority of accumulated p53 in 15d-PGJ2-treated<br />

MCF-7 cells represents a functionally inactive or mutant form as assessed by<br />

immunoprecipitation <strong>and</strong> immunofluorescence analysis. It is anticipated that the electrophilic<br />

carbon center located in the alpha,#-unsaturated carbonyl moiety of the cyclopentenone ring<br />

might be critical for the 15d-PGJ2-induced covalent modification of p53, cysteine thiol,<br />

which retarded its degradation. MCF-7 cells treated with 9,10-dihydro-15-deoxy-&12,14prostagl<strong>and</strong>in<br />

J2 that lacks the electrophilic alpha #-unsaturated functionality failed to<br />

accumulate p53 protein, lending further support to the above assumption. In summary, 15d-<br />

PGJ2 directly conjugates with cysteine thiol residues of p53, interfering its interaction with<br />

MDM2, thereby stabilizing p53. Covalent modification of p53 by 15d-PGJ2 also hampers p53<br />

DNA binding, leading to functional inactivation of this tumor suppressor.<br />

- 637 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!